Asset Publisher

Research

VH-COMSAVAC

Viral Hepatitis COMmunity Screening, Vaccination, and Care

Duration
01/11/2022 - 31/10/2024
Coordinator
Jeffrey Lazarus
Funded by
EU4H European Commission

In 2016, the World Health Organization (WHO) published a global strategy with the goal to eliminate viral hepatitis as a major public health threat by 2030 and set targets to reduce viral hepatitis cases by 90% and hepatitis-related deaths by 65%. The strategy also called for health systems to improve outreach and testing, such that 90% of those unaware of their status are diagnosed and, of these, 80% of people living with HBV and HCV be on treatment by 2030.

Europe’s Beating Cancer Plan was updated in 2021 and sets out specific objectives to reduce cancer-related morbidity and mortality across Europe. The objective to prevent cancers caused by HBV and HCV infections is included in this renewed Plan.

Photo: Candelaria Nazar

The objective of this project is to scale-up and adapt community-based viral hepatitis (HBV and HCV) testing and HBV vaccination models of care among migrant and refugee populations with documented high HBV and HCV incidence and prevalence using simplified diagnostic tools and person-centred referral processes to reduce liver cancer-associated mortality. This project will be carried out in Italy, Greece, and Spain and is coordinated by ISGlobal. 

The project will have a 2-year duration and includes partners in Spain (Salud Entre Culturas), Italy (the Fondazione IRCCS Ca’ Granada Ospedale Maggiore Policlino, Milan; Hospital San Raffaele, and Università Cattolica del Sacro Cuore, Milan), and Greece (Prometheus; Athens).
 

ISGlobal peer-navigators explaining to community members the importance of viral-hepatitis testing. Photo: Candelaria Nazar

External Advisory Board Members 

Associated Partners 

Total funding 

€1 million 

Academic Publications

Related blogposts 

Abstracts presented at conferences

A total of 11 abstracts relating to the VH-COMSAVAC, and its earlier pilot projects (e.g., HBV-COMSAVA) have been presented at national and international conferences including the European Association for the Study of the Liver (EASL) International Liver Conference, the World Hepatitis Summit, the International Viral Hepatitis Elimination Meeting, the European Public Health Association Annual conference, American Association for the Study of the Liver (AASLD) The Liver Meeting®, and the Conference on Liver Diseases in Africa (COLDA). Additionally, two abstracts will be presented at the World Hepatitis Summit in April 2024, and three additional abstracts have been submitted to the EASL Congress in 2024. The 14 abstracts are:

  • Picchio CA, Nicolas A, Kalamitsis G et al. Community-based interventions to increase hepatitis B and hepatitis C virus infection screening among at-risk migrant and refugee populations in Italy, Greece, and Spain: 1 year results of the VH-COMSAVAC project. EASL International Liver Congress 2024. Milan, Italy (Winner of Best Public Health Poster). [VIEW]
  • Picchio CA, Nicolàs A, et al., Lazarus JV. Community-based interventions for HBV and HCV screening and linkage to care among migrants in Spain (Poster presentation) World Hepatitis Summit (WHS), Lisbon (2024) – to be presented
  • Picchio CA, Nicolàs A, et al., Lazarus JV. Community-based HBV screening for migrants to reduce missed opportunities in primary care (Poster presentation) World Hepatitis Summit (WHS), Lisbon (2024) – to be presented
  • Picchio CA, Nomah DK, Rando-Segura, et al., Lazarus JV. A community-based intervention to reduce missed opportunities in primary care for viral hepatitis screening among at-risk African migrants in Catalonia, Spain (Oral presentation) Global Hepatitis Summit (GHS), Paris (2023).
  • Picchio CA, Nomah DK, Rando-Segura, et al., Lazarus JV. Differences in hepatitis B prevalence and linkage to care rates between male and female African migrants participating in a community-based screening program in the greater Barcelona area, Spain. (Poster presentation) International Viral Hepatitis Elimination Meeting (IVHEM), Amsterdam (2022).
  • Picchio CA, Nomah DK, Rando-Segura, et al., Lazarus JV. Community-based screening increases hepatitis B linkage to care among African migrants in Spain. (Poster presentation) European Public Health Association (EUPHA) Annual conference, Berlin (2022). 
  • Picchio CA, Nomah DK, Rando-Segura A, et al., Lazarus JV. Resultados de un proyecto comunitario para aumentar la vacunación y vinculación al cuidado de la hepatitis B en inmigrantes del África occidental en Cataluña: el modelo HBV-COMSAVA. (Oral presentation) Jornadas Catalanas de Salut Internacional, Barcelona (2022).
  • Picchio CA, Rando-Segura A, Fernández, et al., Lazarus JV. HBV screening in West African migrant community and faith-based organizations increased HBV vaccination among this high-risk population in greater Barcelona, Spain. (Poster presentation), EASL International Liver Conference, London, UK (2022).  
  • Picchio CA, Nomah DK, Rando-Segura A, et al., Lazarus JV. Community-based HBV testing among west African migrants in greater Barcelona, Spain increases linkage to specialist care and vaccination: the HBV COMSAVA model. (Poster presentation), EASL International Liver Conference, London, UK (2022).
  • Picchio CA, Araujo SG, Nomah DK, et al., Lazarus JV. Community-based HBV screening increases linkage to care among west African migrants in greater Barcelona, Spain: preliminary data from the HBV-COMSAVA model of care. (Poster presentation) AASLD The Liver Meeting®, [Hybrid, Anaheim, CA] (2021).
  • Picchio CA, Fernández E, Araujo SG, et al., Lazarus JV. Decentralized HBV vaccination in west African community centres in greater Barcelona, Spain to accelerate viral hepatitis elimination: preliminary data from the HBV-COMSAVA model of care. (Poster presentation) Conference on Liver Diseases in Africa (COLDA), [Virtual due to COVID-19] (2021)
  • Picchio CA, Nomah DK, Rando-Segura A, et al., Lazarus JV. HBV-COMSAVA: Preliminary results from a novel community-based hepatitis B screening and linkage to care programme for west African migrants in greater Barcelona, Spain. (Oral presentation) Global Hepatitis Summit, Taipei [Hybrid due to COVID-19] (2021).
  • Picchio CA, Nomah DK, Rando-Segura A, et al., Lazarus JV. Simplifiación del cribado de hepatitis B en Cataluña en población migrante procedente de África occidental: datos preliminares del modelo de cuidado HBV-COMSAVA. (Poster presentation) Asociación Española del Estudio del Higado (AAEH) Congreso [Virtual due to COVID-19] (2021).
  • Picchio CA, Buti M, Kwakye Nomah D, et al., Lazarus JV. Eliminating hepatitis B virus infection in west African migrants in Barcelona: a community-based testing and vaccination model of care to link patients to liver specialists. (Poster presentation) International Viral Hepatitis Elimination Meeting (IVHEM), Amsterdam [Virtual due to COVID-19] (2020).
  • Picchio CA, Kwakye Nomah D, Lazarus JV. HBV awareness and self-reported testing and vaccination in Ghanaian migrants living in the greater Barcelona area participating in a community-based intervention. (Poster presentation) Conference on Liver Diseases in Africa, Dakar [Virtual due to COVID-19] (2020)

Awards and Recognitions 

The VH-COMSAVAC project has won the 2024 Hepatitis “Elimination in Action” Photo Contest, organized by the Coalition for Global Hepatitis Elimination (CGHE). The annual contest received 159 submissions from 24 organizations across 17 countries, highlighting global efforts to eliminate viral hepatitis. A panel of four experts—Danjuma Adda (Past President, World Hepatitis Alliance), Annemarie Wasley (Epidemiologist, Division of Viral Hepatitis, US Centers for Disease Control and Prevention), Piper Hale (Associate Director of Communications, Public Health Informatics Institute), and Victoria Mainardi (Internist and Hepatologist, Hospital Central de Las Fuerzas Armadas de Uruguay, CGHE Elimination Champion)—selected the winning photos based on their powerful depiction of the work in action.

Additional information

VH-COMSAVAC has been featured in the Financial Times in November 2021 and in the HepCast podcast series in October 2022. Further, the project has been publicly presented in webinars and talks hosted by the European Center for Disease Control (ECDC), the International Coalition to Eliminate HBV (ICE-HBV), Liver Patient’s International (LPI) and the Ministry of Health in Argentina, among others:

  • Webinar panelist: “Webinar on testing and care of hepatitis B and C among migrant populations in the EU/EEA” Organized by the European Center for Disease Control (ECDC), European AIDS Clinical Society (EACS) and Centre of Excellence for Health, Immunity, and Infections (CHIP) – 18 Oct 2022.
  • Invited talk: “HBV-Cure research 101 [HBV and migrants in Europe: the HBV-COMSAVA project]” Organized by the International Coalition to Eliminate HBV (ICE-HBV) and Liver Patient’s International (LPI) – 24 Nov 2021.
  • Invited talk: “Call to action for HCV elimination: what is left?” at the XV International Symposium on Viral Hepatitis and Liver Diseases – 01 October 2021. 
  • Invited talk: “Nuevas estrategias en la simplifiación del diagnóstico. Experiencia con población migrante” [New strategies for the simplification of diagnosing. Experience of migrant populations]. World Hepatitis Day 2021 event held by the Ministry of Health of Argentina. – 28 July 2021

The project will also be presented at the in-person technical meeting “Addressing Viral Hepatitis Among Europe's Migrant and Refugee Population: lessons learnt and the way forward” organized by the Viral Hepatitis Prevention Board (VHPB) on March 2024 in Antwerp, Belgium. 

Our Team

Coordinator

ISGlobal team

Other projects

See Past Projects

COMBACTE

Combating Bacterial Resistance In Europe

GAMA

Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

PreFIT

Predicting the Future: Incipient Tuberculosis

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

TB-RECONNECT

Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status

SToolNIH

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

END-VOC

ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.

FLAVOBAC

Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias